168 related articles for article (PubMed ID: 6174446)
61. [Detection of alpha-fetoproteins mRNA and melanoma antigen-1 mRNA in peripheral blood of patients with hepatocellular carcinoma and its clinical significance].
Yang SZ; Dong JH; Zhu J; Li K; Zhang Y
Zhonghua Wai Ke Za Zhi; 2004 Sep; 42(17):1060-3. PubMed ID: 15498320
[TBL] [Abstract][Full Text] [Related]
62. [Clinical significance of AFP-L3 variants determined by micro centrifugal column].
Wang YZ; Luo LB; Wu GX; Chen M; Ruan LH; Pu XK; Hang SR
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Jun; 21(2):135-7. PubMed ID: 17653315
[TBL] [Abstract][Full Text] [Related]
63. Significance of alpha-fetoprotein mRNA level in hepatocellular carcinoma patients treated with radiofrequency ablation.
Du XL; Ma QJ; Wu T; Bao GQ; Lu JG; Chu YK
Hepatobiliary Pancreat Dis Int; 2007 Apr; 6(2):172-5. PubMed ID: 17374577
[TBL] [Abstract][Full Text] [Related]
64. Acarboxy prothrombin (PIVKA II) as a tumour marker for hepatocellular carcinoma and other liver diseases.
Mohamedein A; Yousif-Kadaru AG; Ahmed SA; Saida H; Zaki ZA; Eldin ; Fedail SS
East Afr Med J; 1995 Sep; 72(9):584-7. PubMed ID: 7498046
[TBL] [Abstract][Full Text] [Related]
65. Serum alphafoetoprotein, hepatitis B virus infection and primary hepatocellular carcinoma in Nigerians.
Ola SO; Olubuyide IO; Ayoola EA
East Afr Med J; 1994 Dec; 71(12):782-3. PubMed ID: 7535684
[TBL] [Abstract][Full Text] [Related]
66. Excessive alpha-fetoprotein concentrations in hepatocellular carcinoma.
Amery AH; Alston WC; Kohn J; White WF
Br Med J; 1977 Sep; 2(6087):611-2. PubMed ID: 71184
[No Abstract] [Full Text] [Related]
67. The humoral immune response to p53 in patients with hepatocellular carcinoma is specific for malignancy and independent of the alpha-fetoprotein status.
Volkmann M; Müller M; Hofmann WJ; Meyer M; Hagelstein J; Räth U; Kommerell B; Zentgraf H; Galle PR
Hepatology; 1993 Sep; 18(3):559-65. PubMed ID: 7689531
[TBL] [Abstract][Full Text] [Related]
68. Changing patterns of hepatocellular carcinoma.
Choudhary AM; Roberts I; Gupta T
Am J Gastroenterol; 1999 Sep; 94(9):2571-2. PubMed ID: 10484035
[No Abstract] [Full Text] [Related]
69. Identification of cystatin B as a potential serum marker in hepatocellular carcinoma.
Lee MJ; Yu GR; Park SH; Cho BH; Ahn JS; Park HJ; Song EY; Kim DG
Clin Cancer Res; 2008 Feb; 14(4):1080-9. PubMed ID: 18281540
[TBL] [Abstract][Full Text] [Related]
70. Use of serum PIVKA-II (DCP) determination for differentiation between benign and malignant liver diseases.
Lamerz R; Runge M; Stieber P; Meissner E
Anticancer Res; 1999; 19(4A):2489-93. PubMed ID: 10470180
[TBL] [Abstract][Full Text] [Related]
71. Hepatocellular carcinoma in the non-cirrhotic liver: a comparison with that complicating cirrhosis.
Melia WM; Wilkinson ML; Portmann BC; Johnson PJ; Williams R
Q J Med; 1984; 53(211):391-400. PubMed ID: 6207557
[TBL] [Abstract][Full Text] [Related]
72. Study of alfa feto-protein in hepatomas.
Rao KS; Somayajulu GL; Habeebullah CM
Indian J Pathol Microbiol; 1980 Jul; 23(3):189-91B. PubMed ID: 6161894
[No Abstract] [Full Text] [Related]
73. [Alpha-fetoproteins (AFP)].
Varas Lorenzo MJ
Rev Esp Enferm Apar Dig; 1977 Jun; 50(6):685-94. PubMed ID: 70831
[No Abstract] [Full Text] [Related]
74. Serum alpha-fetoprotein in the early stage of human hepatocellular carcinoma.
Chen DS; Sung JL; Sheu JC; Lai MY; How SW; Hsu HC; Lee CS; Wei TC
Gastroenterology; 1984 Jun; 86(6):1404-9. PubMed ID: 6201411
[TBL] [Abstract][Full Text] [Related]
75. Primary hepatocellular carcinoma in Zimbabwe: frequency of abnormal biochemical investigations.
Marima-Matarira HT; Gudza O
Ann Clin Biochem; 1991 Sep; 28 ( Pt 5)():512-3. PubMed ID: 1720298
[No Abstract] [Full Text] [Related]
76. [Carcinoembryonic antigens].
Burtin P
Pathol Biol (Paris); 1980 Oct; 28(8):489-92. PubMed ID: 6159563
[No Abstract] [Full Text] [Related]
77. The des-gamma-carboxyprothrombin for the diagnosis of hepatocellular carcinoma.
Brunello F; Marcarino C; Pasquero P; Gastaldi P; Gonella S; Martini S; Calcamuggi G; Emanuelli G
Ital J Gastroenterol; 1993 Jan; 25(1):9-12. PubMed ID: 7679014
[TBL] [Abstract][Full Text] [Related]
78. [Correlation between serum alpha-fetoprotein variant levels in patients with hepatocellular carcinoma and the presence of alpha-fetoprotein mRNA in the circulating blood].
Kang XY; Yin ZF; Qian HH; Wu ZD; Yu ZX; Wu MC
Zhonghua Gan Zang Bing Za Zhi; 2003 Jan; 11(1):17-9. PubMed ID: 12546734
[TBL] [Abstract][Full Text] [Related]
79. Comparison of alpha-fetoprotein with some other tumour markers in Malaysians with hepatocellular carcinoma.
Lopez JB; Balasegaram M; Timor J; Thambyrajah V
Malays J Pathol; 1997 Jun; 19(1):53-8. PubMed ID: 10879242
[TBL] [Abstract][Full Text] [Related]
80. Lectin-reactive alpha-fetoprotein in patients with tyrosinemia type I and hepatocellular carcinoma.
Baumann U; Duhme V; Auth MK; McKiernan PJ; Holme E
J Pediatr Gastroenterol Nutr; 2006 Jul; 43(1):77-82. PubMed ID: 16819381
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
